At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Congratulations to Our 2026 Scholarship Recipients
The American Academy of Audiology Foundation’s mission is to promote philanthropy in support of public awareness, research, and education in audiology and hearing and balance…
Senate Passes Continuing Resolution: What It Means for Hearing Health
The Senate recently passed a continuing resolution (CR) to keep the federal government funded through December 11, 2026, giving Congress additional time to complete the…



